Biomea Fusion BMEA
NASDAQ BMEA
$0.69 -0.05 (-6.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Price to Sales (2024 - 2026)

Updated

Analysis

Biomea Fusion (BMEA) Price to Sales (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Biomea Fusion 50.53 Mn -131.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.73
Mar 31, 2026 68.66
Dec 31, 2025 39.71
Sep 30, 2025 20.27
Jun 30, 2025 26.28
Mar 31, 2025 19.54
Dec 31, 2024 24.96
API Access

Biomea Fusion Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=BMEA&period=max&api_key=YOUR_API_KEY